Annual Report for the Financial Year 2025-26.

25th August 2026 The Corporate Relations Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400001 Scrip Code: 544442 Dear Sir/Madam, Sub: FILING OF 7TH ANNUAL REPORT 2025-26 UNDER REGULATION 34(1) THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015. Dear Sir, Please refer to our letter dated 18th August 2026 intimating that the 7th Annual General Meeting (“AGM 2026”) of the Members of the Company is scheduled to be held on Saturday, 19th September 2026 at 12:00 PM IST through Video Conferencing (VC) or Other Audio Video Means (OAVM). Pursuant to Regulation 30 and 34(1) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) as amended from time to time, we are submitting herewith the copy of the Annual Report 2025-26 of the Company. As per the circulars issued by Ministry of Corporate Affairs and SEBI, the aforesaid documents are electronically dispatched to those members whose email IDs are registered with the Company/ Bigshare Services Private Limited ("Registrar and Share Transfer Agent" of the Company) or the Depositories. The Annual Report 2025-26 will also be uploaded on the Company’s website. You are requested to kindly take the note of the above and display the same on notice of the exchange. Thanking you, Kindly take the same on your record. For Chemkart India limited Basavaraj Shankar Dalawai Designation: Chief Financial Officer Enclosed: A/a Your Trusted Partner in Food & Health Ingredients 07TH ANNUAL REPORT 2025-26 [1st Annual Report Post Initial Public Officer (“IPO”)] Global Reach Trusted worldwide connecons Quality Focused High quality ingredients you can trust Customer Centric Soluons tailored to your success Transforming Businesses with Premium Ingredients CHEMKART INDIA LIMITED CIN: L51220MH2020PLC338631 Chairman’s Message Advancing Nutrition. Creating Value. Building a Healthier Tomorrow. Dear Stakeholders, It is a privilege to present the Annual Report of Chemkart India Limited for the financial year ended 31 March 2026. At Chemkart, our vision has always been to be a trusted partner in India's rapidly evolving nutraceucal ecosystem. As health and wellness connue to shape consumer preferences globally, we remain commied to supplying high-quality nutrional ingredients and delivering reliable, customer-centric soluons that enable our clients to develop products that improve lives. Reflecng on Our Journey Since our incepon, we have steadily strengthened our posion as a one-stop sourcing partner for nutraceucal ingredients. Our diversified porolio across amino acids, proteins, vitamins, herbal extracts, health supplements, sports nutrion and nucleodes, supported by our in-house blending and processing capabilies, enables us to cater to the evolving requirements of customers across the value chain. Our growth has been driven by a simple philosophy - building long-term relaonships through quality, consistency, operaonal excellence and ethical business pracces. These principles connue to guide every decision we make. Performance Highlights – FY 2025-26 I am pleased to share that despite a dynamic business environment; the Company connued its growth trajectory during FY 2025-26. Revenue from Operaons increased to ₹ 21,259.48 Lakh from ₹ 20,327.85 Lakh in the previous year, reflecng the resilience of our business model and the confidence our customers place in us. We connued to strengthen our customer base, enhance supply chain efficiencies and expand our product offerings while maintaining our unwavering focus on quality and compliance. Our Growth Priories As we look ahead, our strategy remains focused on sustainable and long-term value creaon through: – Expanding our product porolio across the nutraceucal and health supplement industry. – Strengthening customer relaonships through customized soluons and superior service. – Enhancing operaonal efficiencies through process improvements and technology adopon. – Invesng in quality systems and compliance to meet evolving industry standards. – Exploring new opportunies in value-added manufacturing through our wholly-owned subsidiary to strengthen our presence across the nutraceucal value chain. Looking Ahead The nutraceucal industry in India connues to offer significant opportunies, driven by increasing health awareness, prevenve healthcare trends and growing consumer demand for quality nutrion. We are confident that Chemkart India Limited is well posioned to capitalize on these opportunies through our experienced leadership, dedicated workforce and customer-focused approach. On behalf of the Board of Directors, I extend my sincere gratude to our customers, suppliers, bankers, business associates, shareholders and regulatory authories for their connued trust and support. I also thank our employees for their dedicaon and commitment, which remain the cornerstone of our success. With a clear vision and a strong foundaon, we look forward to creang sustainable value for all our stakeholders while contribung to a healthier future Warm regards, Ankit Shailesh Mehta Chairman & Managing Director Chemkart India Limited Chemkart India Limited INSIDE THIS REPORT CHEMKART INDIA LIMITED CIN: L51220MH2020PLC338631 1. Corporate Informaon 4 2. Noce of 07th Annual General Meeng 5 3. Board of Directors’ Report 21 Annexures to the Board of Directors’ Report 44 Annexure-A: Form AOC-1 44 Annexure-B: Parculars of Employees 45 Annexure-C: Form AOC-2 48 Annexure-D: Annual Report on Corporate Social Responsibility (CSR) Acvies 49 Annexure-E: Secretarial Audit Report 52 Annexure-F: Conservaon of Energy, Technology and Foreign Exchange 56 Annexure-G: Management Discussion and Analysis Report 57 4. Financial Statements and Independent Auditors’ Report (Standalone) 61 5. Financial Statements and Independent Auditors’ Report (Consolidated) 86 www.chemkart.com 3 07 th Annual Report 2025-26 Chemkart India Limited CORPORATE INFORMATION BOARD OF DIRECTORS AND KEY MANAGERIAL PERSONNEL S. No. Name of Directors and KMP Designaon 1 Mr. Ankit Shailesh Mehta Chairman & Managing Director 2 Ms. Parul Shailesh Mehta Execuve Director 3 Mr. Shailesh Vinodrai Mehta Execuve Director 4 Mr. Anirudh Brijkishore Ruia Non-Execuve and Independent Director 5 Mr. Rajesh Vashu Kalro Non-Execuve and Independent Director 6 Mr. Abhishek Sunil Kamdar Non-Execuve and Independent Director 7 Mr. Basavaraj Shankar Dalawai Chief Financial Officer 8 Ms. Shreya Dalmia Company Secretary & Compliance Officer (w.e.f. 20 January 2026) 9 Ms. Ramdulari Saini Company Secretary & Compliance Officer (up to 01 November 2025) STATUTORY AUDITORS BANKERS Bagaria & Co. LLP, Chartered Accountants ICICI Bank Limited, Kotak Mahindra Bank Limited 701, Stanford, Juncon of S. V. Road & Barfiwala Marg, Andheri (W) Mumbai 400058, REGISTERED OFFICE & OTHER DETAILS Maharashtra, INDIA. E-mail id: connect@bagariaco.com Office No. 403/404, 4th Floor, K.L. Accolade, 6th Road, TPS III, Santacruz (East), Mumbai 400055 Maharashtra, INTERNAL AUDITOR INDIA CIN: L51220MH2020PLC338631 M/s N.R. Tibrewala & Co LLP, Chartered Contact: +91 91363 83828 | Accountants (FY 2025-26) Email Id: investors@chemkart.com Office 305, D'Definity, Jaiprakash Nagar Road No. Website: www.chemkart.com 1, Near Railway Staon, Goregaon East, Mumbai - 400063, India AUDIT COMMITTEE Email id: brewalanr@gmail.com Name of the Director Status in Commiee M/s Vinay Bhushan & Associates, Chartered Mr. Rajesh Vashu Kalro Chairman Accountants (FY 2026-27) Mr. Anirudh Brijkishore Ruia Member 726, D-Wing, Neelkanth Business Park, Vidyavihar Mr. Ankit Shailesh Mehta Member (West), Mumbai - 400086, Maharashtra, INDIA E-mail id: audit@vbaconsult.com Name of the Director Status in Commiee Mr. Anirudh Brijkishore Ruia Chairman SECRETARIAL AUDITOR Mr. Abhishek Sunil Kamdar Member M/s Nirmal Tiwari & Associates, Company Ms. Parul Shailesh Meh [Showing first 8,000 characters — download PDF for full document]